E-ISSN: 3048-507X | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access
International Journal of Toxins and Toxics [3048-507X(e)] is a peer-reviewed open-access journal launched in 2024 that aims to publish high-quality research articles and reviews related to all aspects of toxicology.
The Journal welcomes original research articles, reviews, and short …
The target audience for IJT includes toxicologists, environmental scientists, occupational health professionals, pharmacologists, regulatory agencies, and other researchers and professionals interested in toxicology and related fields. The ultimate goal of the journal is to advance knowledge and understanding of toxicology, microbiology, environmental science, toxicology, food science, pharmacology, and public health and to promote the development of safer and more effective strategies for protecting human health and the environment.
ijtt maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Dr. PN Murkey, Professor
Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, India,
Email :
Institutional Profile Link: https://www.mgims.ac.in/index.php/academics/departments/item/pn-murkey
Anabolic-androgenic steroids (AAS) are widely used by athletes and bodybuilders to enhance muscle mass and performance.
Chemical laboratories are considered high-risk work environments due to the wide range of chemicals that workers handle, which may be toxic, corrosive, or flammable.
Cosmeceuticals represent a rapidly expanding category of products positioned between cosmetics and pharmaceuticals, offering both aesthetic and therapeutic benefits.
Drug-induced immune-mediated nephritis (DI-IMN) has become a more widely known cause of acute kidney injury (AKI), with the potential for development to chronic kidney disease if not detected and treated promptly.
Dietary and environmental toxins remain a persistent challenge in food animal production, where subclinical and clinical inflammation compromises health, productivity, and food safety.
Nanotechnology is significantly advancing the pharmaceutical industry by introducing nanosystems that improve drug delivery, therapeutic efficacy, and patient outcomes.
